Assessment of Skin Barrier in Atopic Dermatitis
DOI:
https://doi.org/10.65129/health.v1i2.26Keywords:
Barrier-targeted Therapy, Digital Moisture Monitor, Epidermal Integrity, Lichenification, SCORAD Index, Transepidermal Water Loss (TEWL)Abstract
The skin barrier is a complex protective system that helps maintain many essential functions, including immunology. Atopic Dermatitis (AD) or Atopic Eczema (AE) is a chronic, relapsing, complex inflammatory dermatosis that affects both children and adults, in which the skin’s protective role is disturbed by factors such as genetic predisposition, epidermal barrier disruption, immune regulation abnormalities, and environmental influences. The objective of this study is to assess the severity of barrier disruption in the Skin and to investigate the relationship between moisture level and severity of lesions in patients with Atopic Dermatitis. This cross-sectional analytical study included 30 patients with Atopic Dermatitis (new and known cases) of both genders, aged 18 to 40 years, at the Department of Dermatology, Stanley Medical College Hospital. Examination of Skin with the help of SCORAD score assessment. Digital Moisturometer (To measure the Moisture level of skin by utilizing Bioelectric Impedance Analysis (BIA)) was done and the results were recorded.The participants are categorized as Dry skin and Normal skin based on the Moisture score and categorized as Moderate Atopic Dermatitis and Severe Atopic Dermatitis based on SCORAD score. Among participants with Dry skin, 43.8% had a moderate SCORAD score, while 85.7% had a severe SCORAD score. Among participants with Normal skin, 56.3% had a moderate SCORAD score, while only 14.5% had a severe SCORAD score. Among participants with Normal skin, 14.5% had a severe SCORAD score. The P value is found to be significant (0.017). This research describes the statistically significant relationship between skin moisture level and Atopic Dermatitis severity. This can prove to help investigate interventions to control the barrier integrity to enhance the Quality of life in patients with Atopic Dermatitis.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Journal of Health and Technology

This work is licensed under a Creative Commons Attribution 4.0 International License.
References
1. Swamy AV, Surendran KAK, Swamy NBL, Bangaru H.Epidemiological profile and clinical pattern of atopic dermatitis in South Indian teaching hospital. IP Indian Journal of Clinical and Experimental Dermatology. 2019; 5(2):146-153. https://doi.org/10.18231/j.ijced.2019.032
2. Silverberg JI, et al. Epidemiology of atopic dermatitis: clinical implications. Allergy Clin Immunol Pract. 2021.
3. Barbarot S, et al. Epidemiology of atopic dermatitis in adults. J Eur Acad Dermatol Venereol. 2018.
4. Stalder JF, Barbarot S, Wollenberg A, et al. Patient-oriented SCORAD (PO-SCORAD): A new self-assessment scale in atopic dermatitis validated in Europe. Allergy. 2011; 66(8):1114-21. https://doi.org/10.1111/j.1398-9995.2011.02577.x PMid:21414011.
5. Celakovska J, Bukac J. The severity of atopic dermatitis evaluated with the SCORAD index and the occurrence of bronchial asthma and rhinitis, and the duration of atopic dermatitis. Allergy Rhinol (Providence). 2016; 7(1):8-13. https://doi.org/10.2500/ar.2016.7.0144 PMid:27103554 PMCid:PMC4837137.
6. IADVL’S Concise Textbook of Dermatology; 2019.
7. Elias PM, Steinhoff M. Outside-to-inside (and now back to “outside”) pathogenic mechanisms in atopic dermatitis. J Invest Dermatol. 2008. https://doi.org/10.1038/jid.2008.88 PMid:18408746 PMCid:PMC2675555.
8. Sarkar R, Das A. Atopic Dermatitis: Text and Atlas; 2022.
9. Ellis CN, Mancini AJ, Paller AS, Simpson EL, Eichenfield LF. Understanding and managing atopic dermatitis in adult patients. Semin Cutan Med Surg. 2012; 31(3 Suppl):S18-22. https://doi.org/10.1016/j.sder.2012.07.006 PMid:23021781.
10. De Benedetto, Kubo A, Lisa A. Skin barrier disruption: A requirement for allergen sensitization. J Invest Dermatol. 2012; 132(3 Pt 2):949-63. https://doi.org/10.1038/ jid.2011.435 PMid:22217737 PMCid:PMC3279586.
11. Kim BE, et al. Barrier abnormalities and immune dysregulation in atopic dermatitis. J Allergy Clin Immunol. 2019.
12. Drucker AM, et al. Atopic dermatitis: burden of disease and evidence-based treatment. Am J Clin Dermatol. 2017.
